SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune Inc is currently trending due to intense community speculation surrounding an imminent strategic partnership or buyout for its Pemvidutide asset, which is seen as a potential leader in the MASH and obesity markets. This bullish sentiment is strongly supported by technical indicators pointing to a potential short squeeze and observed institutional interest, leading many investors to anticipate a substantial re-evaluation of the company's valuation.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as CEO Ryan Cohen has significantly increased his stake, publicly challenging other CEOs to demonstrate similar conviction by buying shares with their own money. This substantial insider activity has ignited widespread community excitement, driving speculation about a potential short squeeze and rallying cries like "shorts are f****d." The renewed focus on insider alignment and the re-emergence of the meme stock narrative are fueling intense discussion.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as it formally submitted the first consolidated deep-sea mining application under NOAA's new expedited permitting framework, significantly expanding its proposed commercial recovery area. The community is actively discussing how this, combined with a crucial Congressional hearing on seabed metals for national security, substantially derisks the project and signals potential government backing for critical mineral independence.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending intensely as the market eagerly awaits its upcoming earnings report, with community speculation heavily focused on potential updates regarding its foundry business, AI demand, and possible strategic partnerships. While many anticipate a significant upward move based on a perceived turnaround and strong sector tailwinds, others warn of profit-taking given the substantial rally leading into the announcement, creating palpable tension across the trading community.

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab is generating intense conversation following a significant stock plunge despite its earnings exceeding expectations, fueling widespread speculation about an imminent acquisition at a premium. The community is sharply divided, with many anticipating a rebound from current "oversold" levels, while others highlight persistent valuation concerns and broader software sector headwinds.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is a focal point of discussion as traders grapple with perceived selling pressure from a recent capital raise, despite an influx of bullish analyst upgrades and promising prospects within the rapidly expanding drone and counter-UAS sector. The community is actively debating market manipulation and comparing ONDS's volatile performance to peers, while many long-term investors anticipate significant contract awards and a strong rebound for the stock.

Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.

Ascent Solar Technologies Inc

Ascent Solar Technologies (ASTI) is trending amidst heightened enthusiasm for space infrastructure, specifically driven by recent discussions around solar-powered AI satellites. The community is buzzing about ASTI's unique lightweight, flexible thin-film solar technology, positioning it as a key player for next-generation satellite constellations and defense initiatives. Speculation of significant contract announcements and a potential short squeeze are fueling strong bullish sentiment, despite historical volatility.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending as gold surges to new all-time highs, boosted by an upgraded price target from Goldman Sachs and widespread discussions about its role as a safe haven. While many investors celebrate short squeezes and gold's resilience amidst global uncertainties, a significant segment of the community warns of a speculative 'mania' and anticipates a sharp pullback.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

SXTP is trending following news of its partnership with Runway Health, aiming to broaden telehealth access for its malaria prevention drug, ARAKODA, which has ignited a significant price surge. The community is sharply divided, with bulls celebrating substantial gains and anticipating further upside due to the low float, while skeptics caution about a potential 'pump and dump' and impending dilution.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is experiencing a surge in attention due to its extremely low share float and high short interest, fueling intense community speculation for a significant short squeeze. Traders are actively comparing it to other recent microcap parabolic runners, anticipating substantial price increases as the company explores strategic alternatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

REGENXBIO (NASDAQ:RGNX) Sets New 12-Month High - What's Next?

REGENXBIO (NASDAQ:RGNX) Hits New 52-Week High - Still a Buy...

REGENXBIO Inc. (NASDAQ:RGNX) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine ratings firms that are presently covering the company...

REGENXBIO (NASDAQ:RGNX) Stock Price Down 6.7% - What's Next?

REGENXBIO (NASDAQ:RGNX) Trading Down 6.7% - Should You Sell...

REGENXBIO (NASDAQ:RGNX) Sets New 12-Month High - Here's Why

REGENXBIO (NASDAQ:RGNX) Hits New 12-Month High - Should You Buy...

REGENXBIO (NASDAQ:RGNX) Shares Gap Up - Should You Buy?

REGENXBIO (NASDAQ:RGNX) Shares Gap Up - Time to Buy...

REGENXBIO (NASDAQ:RGNX) Trading Down 3.8% - Here's Why

REGENXBIO (NASDAQ:RGNX) Trading Down 3.8% - What's Next...

REGENXBIO (NASDAQ:RGNX) Hits New 1-Year High - What's Next?

REGENXBIO (NASDAQ:RGNX) Reaches New 52-Week High - Still a Buy...

Assenagon Asset Management S.A. Purchases 132,942 Shares of REGENXBIO Inc. $RGNX

Assenagon Asset Management S.A. increased its position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 23.2% in the third quarter, according to the company in its most recent Form 13F filing with...

REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from Brokerages

REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the firm, Marketbeat Ratings reports. One...

REGENXBIO (NASDAQ:RGNX) Shares Up 9.2% - What's Next?

REGENXBIO (NASDAQ:RGNX) Trading Up 9.2% - What's Next...

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.72	--	--	N/A
Q3 '25	-$1.30	-$1.20	7.81%	BEAT
Q2 '25	-$0.94	-$1.38	-47.14%	MISSED
Q1 '25	$0.46	$0.12	-73.93%	MISSED
Q4 '24	-$1.14	-$1.01	11.48%	BEAT

RGNX
Regenxbio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RGNX News

RGNXRegenxbio Inc